Explore
Validate
LearnABIN966744
antibody from antibodies-online
Targeting: MAPK14
CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN966744 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Mitogen-Activated Protein Kinase 14 (MAPK14) antibody
- Antibody type
- Polyclonal
- Antigen
- The antiserum was produced against synthesized non-phosphopeptide derived from human P38MAPK around the phosphorylation site of tyrosine 182 (T-G-YP-V-A).
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100 μg
- Concentration
- 100ug/100ul.
- Storage
- -20°C
Submitted references Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury.
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.
Zheng M, Reynolds C, Jo SH, Wersto R, Han Q, Xiao RP
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005 Jan;19(1):109-11
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005 Jan;19(1):109-11
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.
van den Blink B, Juffermans NP, ten Hove T, Schultz MJ, van Deventer SJ, van der Poll T, Peppelenbosch MP
Journal of immunology (Baltimore, Md. : 1950) 2001 Jan 1;166(1):582-7
Journal of immunology (Baltimore, Md. : 1950) 2001 Jan 1;166(1):582-7
No comments: Submit comment
No validations: Submit validation data